Jacob Møller, MD, discusses the results of the long anticipated RCT DanGer-Shock Trial. Published in the New England Journal of Medicine and concurrently presented at ACC, DanGer-Shock is a landmark trial in AMI-cardiogenic shock.
Login to view comments.
Click here to Login
